Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 16733
Corporate User License Price USD 750
Corporate User License Price INR 50198
Site License Price USD 500
Site License Price INR 33465
Request a Quote

Report Title

Sichuan Kelun Pharmaceutical Co Ltd (002422)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Sichuan Kelun Pharmaceutical Co Ltd (002422)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Sichuan Kelun Pharmaceutical Co Ltd (002422)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Sichuan Kelun Pharmaceutical Co Ltd (002422)-Pharmaceuticals & Healthcare-Deals and Alliances Profile



Executive Summary

Summary

Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company's products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer's injection, lactated ringer's injection, compound amino acid injection, alanyl glutamine injection, fructose injection, fructose and sodium chloride injection, compound amino acids, fat emulsion injection, vitamin c and glucose injection, vitamin c and sodium chloride injection, kang fu xin solution and lafutidine capsules. It also offers products to serve parenteral nutrition, digestive system, cardiovascular, antipsychotic, respiratory system, anti-pathogenic microorganisms, and APIs and intermediates. Kelun is headquartered in Chengdu, China.

Sichuan Kelun Pharmaceutical Co Ltd (002422)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Debt Offering 11

Sichuan Kelun Pharma to Raise USD116 Million in Public Offering of 4.89% Bonds Due 2022 11

Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 11

Sichuan Kelun Pharma Plans to Raise up to USD269.5 Million in Public Offering of Bonds 12

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2018 For US$175 Million 13

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2017 For US$238 Million 13

Sichuan Kelun Pharma Announces Debt Offering Of Notes Due 2017 For US$412 Million 14

Acquisition 15

Sichuan Kelun Pharma Plans to Acquire 35% stake in Changshu-Based Biotechnology Company 15

Sichuan Kelun Pharma Plans to Acquire Remaining 20% stake in Guangxi-Based Pharmaceutical Unit for USD5.3 Million 16

Sichuan Kelun Pharma Acquires KLUS Pharma for USD13 Million 16

Sichuan Kelun Pharma to Acquire 80% Stake in Biotechnology Company 17

Sichuan Kelun Pharma Plans to Acquire Remaining 15% Stake in Zhejiang-based pharmaceutical unit 17

Sichuan Kelun Pharma Acquires 56% Stake In Chengdu Pharma Company For US$32.8 Million 18

Sichuan Kelun Pharma Acquires Guizhou Kelun Pharma, Pharmaceutical Preparations Manufacturer 18

Sichuan Kelun Pharma Completes Acquisition of 80% Stake in Guilin Dahua Pharma for USD21.9 Million 19

Sichuan Kelun To Acquire 80% Stake In Gui Lin Dahua Pharma 20

Sichuan Kelun Pharmaceutical Co Ltd-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sichuan Kelun Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9

Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sichuan Kelun Pharma to Raise USD116 Million in Public Offering of 4.89% Bonds Due 2022 11

Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 11

Sichuan Kelun Pharma Plans to Raise up to USD269.5 Million in Public Offering of Bonds 12

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2018 For US$175 Million 13

Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2017 For US$238 Million 13

Sichuan Kelun Pharma Announces Debt Offering Of Notes Due 2017 For US$412 Million 14

Sichuan Kelun Pharma Plans to Acquire 35% stake in Changshu-Based Biotechnology Company 15

Sichuan Kelun Pharma Plans to Acquire Remaining 20% stake in Guangxi-Based Pharmaceutical Unit for USD5.3 Million 16

Sichuan Kelun Pharma Acquires KLUS Pharma for USD13 Million 16

Sichuan Kelun Pharma to Acquire 80% Stake in Biotechnology Company 17

Sichuan Kelun Pharma Plans to Acquire Remaining 15% Stake in Zhejiang-based pharmaceutical unit 17

Sichuan Kelun Pharma Acquires 56% Stake In Chengdu Pharma Company For US$32.8 Million 18

Sichuan Kelun Pharma Acquires Guizhou Kelun Pharma, Pharmaceutical Preparations Manufacturer 18

Sichuan Kelun Pharma Completes Acquisition of 80% Stake in Guilin Dahua Pharma for USD21.9 Million 19

Sichuan Kelun To Acquire 80% Stake In Gui Lin Dahua Pharma 20

Sichuan Kelun Pharmaceutical Co Ltd, Key Competitors 21

Sichuan Kelun Pharmaceutical Co Ltd, Key Employees 22

Sichuan Kelun Pharmaceutical Co Ltd, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sichuan Kelun Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand